These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 18688016)

  • 1. Apolipoprotein A-I tryptophan substitution leads to resistance to myeloperoxidase-mediated loss of function.
    Peng DQ; Brubaker G; Wu Z; Zheng L; Willard B; Kinter M; Hazen SL; Smith JD
    Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):2063-70. PubMed ID: 18688016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyrosine modification is not required for myeloperoxidase-induced loss of apolipoprotein A-I functional activities.
    Peng DQ; Wu Z; Brubaker G; Zheng L; Settle M; Gross E; Kinter M; Hazen SL; Smith JD
    J Biol Chem; 2005 Oct; 280(40):33775-84. PubMed ID: 16091367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloperoxidase impairs ABCA1-dependent cholesterol efflux through methionine oxidation and site-specific tyrosine chlorination of apolipoprotein A-I.
    Shao B; Oda MN; Bergt C; Fu X; Green PS; Brot N; Oram JF; Heinecke JW
    J Biol Chem; 2006 Apr; 281(14):9001-4. PubMed ID: 16497665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosine 192 in apolipoprotein A-I is the major site of nitration and chlorination by myeloperoxidase, but only chlorination markedly impairs ABCA1-dependent cholesterol transport.
    Shao B; Bergt C; Fu X; Green P; Voss JC; Oda MN; Oram JF; Heinecke JW
    J Biol Chem; 2005 Feb; 280(7):5983-93. PubMed ID: 15574409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humans with atherosclerosis have impaired ABCA1 cholesterol efflux and enhanced high-density lipoprotein oxidation by myeloperoxidase.
    Shao B; Tang C; Sinha A; Mayer PS; Davenport GD; Brot N; Oda MN; Zhao XQ; Heinecke JW
    Circ Res; 2014 May; 114(11):1733-42. PubMed ID: 24647144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of nitration and chlorination sites on apolipoprotein A-I catalyzed by myeloperoxidase in human atheroma and associated oxidative impairment in ABCA1-dependent cholesterol efflux from macrophages.
    Zheng L; Settle M; Brubaker G; Schmitt D; Hazen SL; Smith JD; Kinter M
    J Biol Chem; 2005 Jan; 280(1):38-47. PubMed ID: 15498770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acrolein impairs ATP binding cassette transporter A1-dependent cholesterol export from cells through site-specific modification of apolipoprotein A-I.
    Shao B; Fu X; McDonald TO; Green PS; Uchida K; O'Brien KD; Oram JF; Heinecke JW
    J Biol Chem; 2005 Oct; 280(43):36386-96. PubMed ID: 16126721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein A-I lysine modification: effects on helical content, lipid binding and cholesterol acceptor activity.
    Brubaker G; Peng DQ; Somerlot B; Abdollahian DJ; Smith JD
    Biochim Biophys Acta; 2006 Jan; 1761(1):64-72. PubMed ID: 16495141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease.
    Zheng L; Nukuna B; Brennan ML; Sun M; Goormastic M; Settle M; Schmitt D; Fu X; Thomson L; Fox PL; Ischiropoulos H; Smith JD; Kinter M; Hazen SL
    J Clin Invest; 2004 Aug; 114(4):529-41. PubMed ID: 15314690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HDL from apoA1 transgenic mice expressing the 4WF isoform is resistant to oxidative loss of function.
    Berisha SZ; Brubaker G; Kasumov T; Hung KT; DiBello PM; Huang Y; Li L; Willard B; Pollard KA; Nagy LE; Hazen SL; Smith JD
    J Lipid Res; 2015 Mar; 56(3):653-664. PubMed ID: 25561462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pathway-dependent on apoE, ApoAI, and ABCA1 determines formation of buoyant high-density lipoprotein by macrophage foam cells.
    Yancey PG; Yu H; Linton MF; Fazio S
    Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1123-31. PubMed ID: 17303773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloperoxidase: an inflammatory enzyme for generating dysfunctional high density lipoprotein.
    Shao B; Oda MN; Oram JF; Heinecke JW
    Curr Opin Cardiol; 2006 Jul; 21(4):322-8. PubMed ID: 16755201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Site-specific 5-hydroxytryptophan incorporation into apolipoprotein A-I impairs cholesterol efflux activity and high-density lipoprotein biogenesis.
    Zamanian-Daryoush M; Gogonea V; DiDonato AJ; Buffa JA; Choucair I; Levison BS; Hughes RA; Ellington AD; Huang Y; Li XS; DiDonato JA; Hazen SL
    J Biol Chem; 2020 Apr; 295(15):4836-4848. PubMed ID: 32098873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ABCA1 Overexpression in Endothelial Cells In Vitro Enhances ApoAI-Mediated Cholesterol Efflux and Decreases Inflammation.
    Stamatikos A; Dronadula N; Ng P; Palmer D; Knight E; Wacker BK; Tang C; Kim F; Dichek DA
    Hum Gene Ther; 2019 Feb; 30(2):236-248. PubMed ID: 30079772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein A-I configuration and cell cholesterol efflux activity of discoidal lipoproteins depend on the reconstitution process.
    Cuellar LÁ; Prieto ED; Cabaleiro LV; Garda HA
    Biochim Biophys Acta; 2014 Jan; 1841(1):180-9. PubMed ID: 24201377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the role of phosphatidylserine translocase activity in ABCA1-mediated lipid efflux.
    Smith JD; Waelde C; Horwitz A; Zheng P
    J Biol Chem; 2002 May; 277(20):17797-803. PubMed ID: 11893753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysfunctional HDL as a diagnostic and therapeutic target.
    Smith JD
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):151-5. PubMed ID: 19679832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The central helices of ApoA-I can promote ATP-binding cassette transporter A1 (ABCA1)-mediated lipid efflux. Amino acid residues 220-231 of the wild-type ApoA-I are required for lipid efflux in vitro and high density lipoprotein formation in vivo.
    Chroni A; Liu T; Gorshkova I; Kan HY; Uehara Y; Von Eckardstein A; Zannis VI
    J Biol Chem; 2003 Feb; 278(9):6719-30. PubMed ID: 12488454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathways for oxidation of high-density lipoprotein in human cardiovascular disease.
    Shao B; Oda MN; Vaisar T; Oram JF; Heinecke JW
    Curr Opin Mol Ther; 2006 Jun; 8(3):198-205. PubMed ID: 16774039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of high density lipoprotein by myeloperoxidase generates a pro-inflammatory particle.
    Undurti A; Huang Y; Lupica JA; Smith JD; DiDonato JA; Hazen SL
    J Biol Chem; 2009 Nov; 284(45):30825-35. PubMed ID: 19726691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.